Curetis USA is focused on delivering fast, reliable and cost-effective molecular solutions to aid in diagnosing severe infectious diseases. Now the first FDA approved molecular diagnostic panel for lower respiratory tract infections, Curetis’ Unyvero System provides clinicians with rapid and critical information for the early detection of Lower Respiratory Tract microorganisms and their associated antibiotic resistance markers. Additional applications are in development for Invasive Joint Infections, Intra-Abdominal Infections, Blood Culture and Urinary Tract Infections.